Home / Health / U.S. FDA approves Catalyst Pharma's rare disease drug

U.S. FDA approves Catalyst Pharma's rare disease drug

November 29, 2018 Health

The U.S. Food and Drug Administration approved on Wednesday Catalyst Pharmaceuticals Inc's drug to treat a rare autoimmune disease.

from Reuters: Health https://ift.tt/2TQZcyC

No comments

Subscribe to: Post Comments ( Atom )